Suppression of xenogeneic innate immune response by a membrane-type human surfactant protein-A

Chiyoshi Toyama1, Akira Maeda1, Shuhei Kogata1

  • 1Department of Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.

Insights

Surfactant protein-A (SP-A) can suppress macrophage attacks on foreign cells. Expressing SP-A in pig cells reduced cell damage and inflammation, offering a new way to prevent rejection.

Area of Science:

  • Immunology
  • Xenotransplantation

Background:

  • Macrophage-mediated xenogeneic rejection is a significant hurdle in xenotransplantation.
  • Membrane-type surfactant protein-D (SP-D) has shown potential in suppressing this rejection.
  • Surfactant protein-A (SP-A), similar to SP-D, possesses inhibitory signaling capabilities.

Purpose of the Study:

  • To investigate the suppressive effect of SP-A on macrophage-mediated xenogeneic rejection.
  • To evaluate SP-A's impact on the cytotoxicity and phagocytosis of swine endothelial cells (SECs).

Main Methods:

  • Co-culture of naive SECs and SP-A-transfected SECs (SEC/SP-A) with THP-1 cells to assess cytotoxicity.
  • Flow cytometry analysis of phagocytosis and reactive oxygen species (ROS) production by human macrophages co-cultured with SEC or SEC/SP-A.
  • Reverse transcription-PCR to measure inflammatory cytokine mRNA levels (TNFα, IL-10) in macrophages.
  • Evaluation of NF-κB transcription factor activity.

Main Results:

  • SEC/SP-A exhibited significantly reduced cytotoxicity and phagocytosis compared to naive SECs.
  • Co-culture with SEC/SP-A led to decreased ROS production in human macrophages.
  • Macrophages showed reduced TNFα and increased IL-10 mRNA expression.
  • NF-κB transcription was suppressed in SEC/SP-A compared to SEC.

Conclusions:

  • Ectopic expression of human SP-A in porcine cells effectively suppresses macrophage-mediated cytotoxicity.
  • SP-A holds promise as a strategy to mitigate xenogeneic rejection in transplantation.